Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 06:56:34 UTC |
---|
Update Date | 2021-09-26 23:01:09 UTC |
---|
HMDB ID | HMDB0249976 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide |
---|
Description | N-[1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-{[hydroxy(morpholin-4-yl)methylidene]amino}-3-phenylpropanimidic acid belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Based on a literature review very few articles have been published on N-[1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-{[hydroxy(morpholin-4-yl)methylidene]amino}-3-phenylpropanimidic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[(2s)-1-[[(e,3s)-1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | O=C(NC(CCC1=CC=CC=C1)C=CS(=O)(=O)C1=CC=CC=C1)C(CC1=CC=CC=C1)NC(=O)N1CCOCC1 InChI=1S/C31H35N3O5S/c35-30(29(24-26-12-6-2-7-13-26)33-31(36)34-19-21-39-22-20-34)32-27(17-16-25-10-4-1-5-11-25)18-23-40(37,38)28-14-8-3-9-15-28/h1-15,18,23,27,29H,16-17,19-22,24H2,(H,32,35)(H,33,36) |
---|
Synonyms | Value | Source |
---|
N-[1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-{[hydroxy(morpholin-4-yl)methylidene]amino}-3-phenylpropanimidate | Generator | N-[1-(Benzenesulphonyl)-5-phenylpent-1-en-3-yl]-2-{[hydroxy(morpholin-4-yl)methylidene]amino}-3-phenylpropanimidate | Generator | N-[1-(Benzenesulphonyl)-5-phenylpent-1-en-3-yl]-2-{[hydroxy(morpholin-4-yl)methylidene]amino}-3-phenylpropanimidic acid | Generator | N-[(2S)-1-[[(e,3S)-1-(Benzenesulphonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide | Generator |
|
---|
Chemical Formula | C31H35N3O5S |
---|
Average Molecular Weight | 561.7 |
---|
Monoisotopic Molecular Weight | 561.229742413 |
---|
IUPAC Name | N-[1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-[(morpholine-4-carbonyl)amino]-3-phenylpropanamide |
---|
Traditional Name | N-[1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]-2-(morpholine-4-carbonylamino)-3-phenylpropanamide |
---|
CAS Registry Number | Not Available |
---|
SMILES | O=C(NC(CCC1=CC=CC=C1)C=CS(=O)(=O)C1=CC=CC=C1)C(CC1=CC=CC=C1)NC(=O)N1CCOCC1 |
---|
InChI Identifier | InChI=1S/C31H35N3O5S/c35-30(29(24-26-12-6-2-7-13-26)33-31(36)34-19-21-39-22-20-34)32-27(17-16-25-10-4-1-5-11-25)18-23-40(37,38)28-14-8-3-9-15-28/h1-15,18,23,27,29H,16-17,19-22,24H2,(H,32,35)(H,33,36) |
---|
InChI Key | HSZIWISHLSFWJO-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Phenylalanine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Phenylalanine or derivatives
- N-carbamoyl-alpha-amino acid or derivatives
- Alpha-amino acid amide
- Amphetamine or derivatives
- Benzenesulfonyl group
- Morpholine-4-carboxylic acid or derivatives
- Fatty acyl
- Benzenoid
- Oxazinane
- Morpholine
- Fatty amide
- Monocyclic benzene moiety
- Sulfonyl
- Sulfone
- Urea
- Secondary carboxylic acid amide
- Carbonic acid derivative
- Carboxamide group
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Ether
- Dialkyl ether
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Carbonyl group
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredictor | Adduct Type | CCS Value (Å2) | Reference |
---|
DeepCCS | [M+H]+ | 216.603 | 30932474 | DeepCCS | [M-H]- | 214.207 | 30932474 | DeepCCS | [M-2H]- | 247.091 | 30932474 | DeepCCS | [M+Na]+ | 222.515 | 30932474 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4669.3 | Semi standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 3899.2 | Standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 6050.7 | Standard polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TMS,isomer #2 | C[Si](C)(C)N(C(=O)N1CCOCC1)C(CC1=CC=CC=C1)C(=O)NC(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4556.2 | Semi standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TMS,isomer #2 | C[Si](C)(C)N(C(=O)N1CCOCC1)C(CC1=CC=CC=C1)C(=O)NC(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 3875.1 | Standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TMS,isomer #2 | C[Si](C)(C)N(C(=O)N1CCOCC1)C(CC1=CC=CC=C1)C(=O)NC(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 5934.2 | Standard polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)N(C(=O)N1CCOCC1)[Si](C)(C)C)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4435.8 | Semi standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)N(C(=O)N1CCOCC1)[Si](C)(C)C)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 3976.6 | Standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)N(C(=O)N1CCOCC1)[Si](C)(C)C)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 5641.0 | Standard polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4916.2 | Semi standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4122.8 | Standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)NC(=O)N1CCOCC1)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 6006.3 | Standard polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=O)N1CCOCC1)C(CC1=CC=CC=C1)C(=O)NC(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4801.7 | Semi standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=O)N1CCOCC1)C(CC1=CC=CC=C1)C(=O)NC(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4088.3 | Standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N(C(=O)N1CCOCC1)C(CC1=CC=CC=C1)C(=O)NC(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 5886.8 | Standard polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)N(C(=O)N1CCOCC1)[Si](C)(C)C(C)(C)C)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4912.8 | Semi standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)N(C(=O)N1CCOCC1)[Si](C)(C)C(C)(C)C)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 4426.6 | Standard non polar | 33892256 | N-[(2S)-1-[[(E,3S)-1-(Benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]morpholine-4-carboxamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C(CC1=CC=CC=C1)N(C(=O)N1CCOCC1)[Si](C)(C)C(C)(C)C)C(C=CS(=O)(=O)C1=CC=CC=C1)CCC1=CC=CC=C1 | 5558.9 | Standard polar | 33892256 |
|
---|